Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cognitive Deficit in Schizophrenia”

182 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 182 results

Not applicableLooking for participantsNCT07139171
What this trial is testing

Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia

Who this might be right for
Schizophrenia
Tianjin Anding Hospital 300
Early research (Phase 1)Study completedNCT02079844
What this trial is testing

Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia

Who this might be right for
Schizophrenia
Takeda 20
Testing effectiveness (Phase 2)Ended earlyNCT00439634
What this trial is testing

Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia

Who this might be right for
Schizophrenia
Sanofi 873
Testing effectiveness (Phase 2)Study completedNCT00506077
What this trial is testing

MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)

Who this might be right for
Paranoid Schizophrenia
Merck Sharp & Dohme LLC 55
Not applicableEnrolling By InvitationNCT07162467
What this trial is testing

Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.

Who this might be right for
Schizophrenia
Tianjin Anding Hospital 200
Early research (Phase 1)Study completedNCT02332798
What this trial is testing

Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia

Who this might be right for
Schizophrenia
Biogen 39
Not applicableStudy completedNCT07137572
What this trial is testing

Arts-based Social Prescribing for Mental Health

Who this might be right for
Mental Health IssueAnxiety DisordersAffective Disorders+7 more
KAVADIA ELENI 541
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06315972
What this trial is testing

Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity

Who this might be right for
Schizophrenia
LMU Klinikum 90
Not applicableStudy completedNCT03775564
What this trial is testing

Effectiveness of the RemedRugby Program

Who this might be right for
SchizophreniaSocial CognitionSelf Esteem+2 more
Hospital Center Alpes-Isère 60
Not applicableStudy completedNCT01773239
What this trial is testing

Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia

Who this might be right for
Schizophrenia
Posit Science Corporation 16
Testing effectiveness (Phase 2)Study completedNCT02524899
What this trial is testing

CRT-Guanfacine for SPD

Who this might be right for
Schizotypal Personality DisorderSPD
Icahn School of Medicine at Mount Sinai 45
Not applicableStudy completedNCT00001258
What this trial is testing

Studies of Frontal Lobe Brain Functioning in Schizophrenia

Who this might be right for
Healthy SubjectsSchizophreniaParkinson Disease
National Institute of Mental Health (NIMH) 1,039
Testing effectiveness (Phase 2)Study completedNCT01655680
What this trial is testing

Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia

Who this might be right for
Schizophrenia
AbbVie (prior sponsor, Abbott) 432
Not applicableUnknownNCT00138021
What this trial is testing

Cognitive Remediation in Supported Employment at Human Service Center (HSC)

Who this might be right for
Vocational RehabilitationSchizophreniaMental Disorders+1 more
Human Service Center, Illinois 50
Testing effectiveness (Phase 2)Study completedNCT01077700
What this trial is testing

Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia

Who this might be right for
Cognitive Deficits in Schizophrenia
AbbVie (prior sponsor, Abbott) 214
Post-approval studies (Phase 4)Study completedNCT00802919
What this trial is testing

Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors

Who this might be right for
SchizophreniaCigarette Smoking
Nathan Kline Institute for Psychiatric Research 93
Post-approval studies (Phase 4)Study completedNCT02505477
What this trial is testing

Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine

Who this might be right for
SchizophreniaCognitive DeficitsSchizophrenia; Negative Type
University of California, Los Angeles 51
Not applicableStudy completedNCT01078129
What this trial is testing

Cognitive Remediation Therapy and Schizophrenia

Who this might be right for
Schizophrenia
Hôpital le Vinatier 77
Testing effectiveness (Phase 2)Ended earlyNCT00548327
What this trial is testing

The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype

Who this might be right for
SchizophreniaMemory DisordersCognition Disorders
National Institute of Mental Health (NIMH) 11
Not applicableNot Yet RecruitingNCT06474286
What this trial is testing

Prucalopride for Cognitive Functioning in Schizophrenia

Who this might be right for
Schizophrenia
University of Pittsburgh 34
Load More Results